Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Hutchmed Share News (HCM)
HCM Share
Price
HCM Share
News
HCM Share
Chat2
HCM Share
Trades60
HCM
Live RNS
HCM Share
Charts
HCM Level 2
Console
HCM Live
Share Price
HCM Broker
Ratings
HCM Directors
Deals
HCM Financial
Diary
HCM
Fundamentals
HCM Short
Positions
HCM
Media
HCM Company
Research
HCM Company
Timeline
Hutchmed Information
Share Price Information for Hutchmed (HCM)
Share Price is delayed by 15 minutes
Get Live Data
170.50
5.75 (3.49%)
Bid:
168.00
Ask:
172.00
Spread:
4.00 (2.381%)
Market Cap:
£1.47b
Last checked at -
Last checked at 
Intraday Hutchmed Share Chart
Hutchmed News
24 Nov 2021
Hutchmed China shares rise on Orphathys and Tagrisso Phase 3 study
Hutchmed China shares rise on Orphathys and Tagrisso Phase 3 study
1 Nov 2021
TOP NEWS: Astra transfers drug rights to Covis in USD270 million deal
TOP NEWS: Astra transfers drug rights to Covis in USD270 million deal
28 Oct 2021
IN BRIEF: Hutchmed begins phase 3 trial of thrombocytopenia drug
IN BRIEF: Hutchmed begins phase 3 trial of thrombocytopenia drug
29 Sep 2021
Hutchmed China sells joint venture stake for USD169 million
Hutchmed China sells joint venture stake for USD169 million
21 Sep 2021
Hutchmed starts drug combination trial for neuroendocrine tumours
Hutchmed starts drug combination trial for neuroendocrine tumours
20 Sep 2021
Hutchmed starts Japan trial for surufatinib in neuroendocrine tumors
Hutchmed starts Japan trial for surufatinib in neuroendocrine tumors
13 Sep 2021
Hutchmed China's amdizalisib secures breakthrough therapy designation
Hutchmed China's amdizalisib secures breakthrough therapy designation
8 Sep 2021
Hutchmed, Astra launch drug combination trial to treat lung cancer
Hutchmed, Astra launch drug combination trial to treat lung cancer
Follow the stocks
